BRIDGEBIO PHARMA INC's ticker is BBIO and the CUSIP is 10806X102. A total of 75 filers reported holding BRIDGEBIO PHARMA INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $175,044 | +62.6% | 6,638 | +6.1% | 0.01% | +80.0% |
| Q2 2023 | $107,638 | +10.3% | 6,258 | +6.3% | 0.01% | 0.0% |
| Q1 2023 | $97,590 | +88.7% | 5,886 | -13.3% | 0.01% | +150.0% |
| Q4 2022 | $51,725 | -23.3% | 6,788 | 0.0% | 0.00% | -33.3% |
| Q3 2022 | $67,473 | +9.5% | 6,788 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $61,635 | -10.5% | 6,788 | 0.0% | 0.00% | +50.0% |
| Q1 2022 | $68,898 | -84.6% | 6,788 | -74.8% | 0.00% | -66.7% |
| Q4 2021 | $448,775 | -66.4% | 26,905 | -5.5% | 0.01% | -68.4% |
| Q3 2021 | $1,334,155 | -25.4% | 28,465 | -3.0% | 0.02% | -24.0% |
| Q2 2021 | $1,788,810 | +14.0% | 29,344 | +15.2% | 0.02% | +8.7% |
| Q1 2021 | $1,569,753 | +5.1% | 25,483 | +21.3% | 0.02% | +4.5% |
| Q4 2020 | $1,493,666 | +89.5% | 21,005 | 0.0% | 0.02% | +57.1% |
| Q3 2020 | $788,108 | +6.5% | 21,005 | -7.5% | 0.01% | +7.7% |
| Q2 2020 | $740,149 | +12.4% | 22,697 | 0.0% | 0.01% | -7.1% |
| Q1 2020 | $658,213 | +150.6% | 22,697 | +202.9% | 0.01% | +250.0% |
| Q4 2019 | $262,665 | +13.0% | 7,494 | -30.8% | 0.00% | 0.0% |
| Q3 2019 | $232,520 | – | 10,830 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aisling Capital Management LP | 6,068,125 | $55,099,000 | 39.31% |
| M28 Capital Management LP | 466,200 | $4,233,000 | 4.74% |
| Kohlberg Kravis Roberts & Co. L.P. | 31,060,971 | $282,034,000 | 3.75% |
| Octagon Capital Advisors LP | 933,743 | $8,478,000 | 2.26% |
| VIKING GLOBAL INVESTORS LP | 26,620,991 | $241,719,000 | 1.11% |
| HHLR ADVISORS, LTD. | 5,362,014 | $48,687,000 | 1.04% |
| Cormorant Asset Management, LP | 1,469,179 | $13,340,000 | 1.01% |
| Knott David M Jr | 213,206 | $1,936,000 | 0.81% |
| Fernwood Investment Management, LLC | 183,900 | $1,670,000 | 0.72% |
| HighVista Strategies LLC | 105,942 | $962,000 | 0.58% |